GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Lifecare ASA (OSL:LIFE) » Definitions » Intrinsic Value: Projected FCF

Lifecare ASA (OSL:LIFE) Intrinsic Value: Projected FCF : kr-0.44 (As of Jun. 03, 2025)


View and export this data going back to 2018. Start your Free Trial

What is Lifecare ASA Intrinsic Value: Projected FCF?

Since the intrinsic value calculations based on Discounted Cash Flow Intrinsic Value: DCF (FCF Based), or Discounted Earnings Intrinsic Value: DCF (Earnings Based) cannot be applied to companies without consistent revenue and earnings, GuruFocus developed a valuation model based on normalized Free Cash Flow and Book Value of the company. The details of how we calculate the intrinsic value of stocks are described in detail here.

As of today (2025-06-03), Lifecare ASA's Intrinsic Value: Projected FCF is kr-0.44. The stock price of Lifecare ASA is kr6.30. Therefore, Lifecare ASA's Price-to-Intrinsic-Value-Projected-FCF of today is 0.0.

The historical rank and industry rank for Lifecare ASA's Intrinsic Value: Projected FCF or its related term are showing as below:

OSL:LIFE's Price-to-Projected-FCF is not ranked *
in the Medical Devices & Instruments industry.
Industry Median: 1.53
* Ranked among companies with meaningful Price-to-Projected-FCF only.

Lifecare ASA Intrinsic Value: Projected FCF Historical Data

The historical data trend for Lifecare ASA's Intrinsic Value: Projected FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Lifecare ASA Intrinsic Value: Projected FCF Chart

Lifecare ASA Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Intrinsic Value: Projected FCF
Get a 7-Day Free Trial Premium Member Only Premium Member Only - -0.12 -0.17 -0.44 -

Lifecare ASA Quarterly Data
Dec16 Dec17 Jun18 Dec18 Jun19 Dec19 Dec20 Jun21 Dec21 Jun22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Intrinsic Value: Projected FCF Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Lifecare ASA's Intrinsic Value: Projected FCF

For the Medical Devices subindustry, Lifecare ASA's Price-to-Projected-FCF, along with its competitors' market caps and Price-to-Projected-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Lifecare ASA's Price-to-Projected-FCF Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Lifecare ASA's Price-to-Projected-FCF distribution charts can be found below:

* The bar in red indicates where Lifecare ASA's Price-to-Projected-FCF falls into.


;
;

Lifecare ASA Intrinsic Value: Projected FCF Calculation

Since the intrinsic value calculations based on Discounted Cash Flow Intrinsic Value: DCF (FCF Based), or Discounted Earnings Intrinsic Value: DCF (Earnings Based) cannot be applied to companies without consistent revenue and earnings, GuruFocus developed a valuation model based on normalized Free Cash Flow and Book Value of the company.

The details of how we calculate the intrinsic value of stocks are described in detail here.

This method smooths out the free cash flow over the past 6-7 years, multiplies the results by a growth multiple, and adds a portion of Total Stockholders Equity.

Intrinsic Value: Projected FCF = ( Growth Multiple * Free Cash Flow (6 year avg) + 0.8 * Total Stockholders Equity (most recent) ) / Shares Outstanding (Diluted Average)

In the case of negative Total Stockholders Equity, the following formula is used (see Explanation section below for the reason):

Intrinsic Value: Projected FCF = ( Growth Multiple * Free Cash Flow (6 year avg) + Total Stockholders Equity (most recent) / 0.8 ) / Shares Outstanding (Diluted Average)



Lifecare ASA  (OSL:LIFE) Intrinsic Value: Projected FCF Explanation

The growth multiple is capped between 8.35 and 17.74.

Total Stockholders Equity weighting is more art than science and it should always be revisited in more detail when researching a company. Weightings from 0% to 100% to more than 100% are possible. 80% was chosen as a happy median after taking the above ideas into consideration.

Lifecare ASA's Price-to-Intrinsic-Value-Projected-FCF for today is calculated as

Price-to-Intrinsic-Value-Projected-FCF=Share Price/Intrinsic Value: Projected FCF
=6.30/
=

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Lifecare ASA Intrinsic Value: Projected FCF Related Terms

Thank you for viewing the detailed overview of Lifecare ASA's Intrinsic Value: Projected FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


Lifecare ASA Business Description

Traded in Other Exchanges
Address
Ytrebygdsvegen 215, Blomsterdalen, Bergen, NOR, 5258
Lifecare ASA focuses on the research, development, and commercialization of sensor technology for continuous monitoring of body analytes. Lifecare develops and licenses nanotechnology for medical use to facilitate the production and sale of medical devices. Its miniaturized sensor technology measures changes by reading osmotic pressure variations in a small chamber, and can, e.g., measure glucose and lactate levels by applying different chemical compositions. The company operates as a single segment focused on research and development (R&D) of its osmotic pressure sensor and related components.

Lifecare ASA Headlines

No Headlines